These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17287732)

  • 1. Commercial interest grows in glycan analysis.
    Sheridan C
    Nat Biotechnol; 2007 Feb; 25(2):145-6. PubMed ID: 17287732
    [No Abstract]   [Full Text] [Related]  

  • 2. What's fueling the biotech engine?
    Aggarwal S
    Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
    [No Abstract]   [Full Text] [Related]  

  • 3. Biomanufacturing, from bust to boom...to bubble?
    Thiel KA
    Nat Biotechnol; 2004 Nov; 22(11):1365-72. PubMed ID: 15529157
    [No Abstract]   [Full Text] [Related]  

  • 4. The shape of European business in 2003.
    Wagner M
    Med Device Technol; 2002 Dec; 13(10):8-10. PubMed ID: 12575520
    [No Abstract]   [Full Text] [Related]  

  • 5. The biotechnology industry: What's next?
    Guertin PA
    Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech patenting slows in 2004.
    Lawrence S
    Nat Biotechnol; 2005 Oct; 23(10):1198. PubMed ID: 16211048
    [No Abstract]   [Full Text] [Related]  

  • 7. China's biotech is starting to bloom.
    Stipp D
    Fortune; 2002 Sep; 146(4):126-30, 132, 134. PubMed ID: 12195673
    [No Abstract]   [Full Text] [Related]  

  • 8. Western biotechs ponder follow-on possibilities.
    Waltz E
    Nat Biotechnol; 2008 Sep; 26(9):962-3. PubMed ID: 18779793
    [No Abstract]   [Full Text] [Related]  

  • 9. First inhalable insulin approved.
    Katsnelson A
    Nat Biotechnol; 2006 Apr; 24(4):369-70. PubMed ID: 16601705
    [No Abstract]   [Full Text] [Related]  

  • 10. Gaining medical momentum.
    Blake D
    Nature; 2004 Jun; 429(6991 Suppl):19-23. PubMed ID: 15175707
    [No Abstract]   [Full Text] [Related]  

  • 11. BTJ Forum: Biotech in the financial crisis.
    Biotechnol J; 2009 Aug; 4(8):1108-10. PubMed ID: 19685461
    [No Abstract]   [Full Text] [Related]  

  • 12. New development of glycan arrays.
    Wu CY; Liang PH; Wong CH
    Org Biomol Chem; 2009 Jun; 7(11):2247-54. PubMed ID: 19462030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commercial interest waxes for IGF-1 blockers.
    Osborne R
    Nat Biotechnol; 2008 Jul; 26(7):719-20. PubMed ID: 18612276
    [No Abstract]   [Full Text] [Related]  

  • 14. Cambridge: Europe's leading location for biotechnology.
    Walker J
    Drug Discov Today; 2005 Jul; 10(14):956-9. PubMed ID: 16023052
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceutical industry financial performance.
    Goodman M
    Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398
    [No Abstract]   [Full Text] [Related]  

  • 16. Chiral-based therapeutics.
    Persidis A
    Nat Biotechnol; 1997 Jun; 15(6):594-5. PubMed ID: 9181585
    [No Abstract]   [Full Text] [Related]  

  • 17. The business of RNAi therapeutics.
    Haussecker D
    Hum Gene Ther; 2008 May; 19(5):451-62. PubMed ID: 18435603
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmas partner in venture seeking drug discovery tools.
    Mack GS
    Nat Biotechnol; 2008 Sep; 26(9):960-1. PubMed ID: 18779790
    [No Abstract]   [Full Text] [Related]  

  • 19. A new era in the European marketplace.
    Wagner M
    Mod Healthc; 1990 Oct; 20(39):26-7, 30-3. PubMed ID: 10170601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Europe caught in innovation quagmire.
    Mitchell P
    Nat Biotechnol; 2005 Sep; 23(9):1029. PubMed ID: 16151378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.